The Pathogenesis and Genetics of Environmental Asthma

环境性哮喘的发病机制和遗传学

基本信息

  • 批准号:
    6677838
  • 负责人:
  • 金额:
    $ 146.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-09-15 至 2008-06-30
  • 项目状态:
    已结题

项目摘要

The overall theme of this Program Project Grant (P01) is to understand further the pathogenesis and genetics of asthma by studying environmental airway disease. We chose this theme for our PPG for the following reasons: 1) the symptoms and signs of asthma constitute a broad clinical phenotype; 2) asthma is a complex genetic disease caused by many biologically unique gene-gene and gene-environment interactions; 3) environmental models of airway disease serve to narrow the biological phenotype of asthma, providing an ideal opportunity to study the pathogenesis and genetics of this complex disease; and 4) this theme builds on existing scientific expertise and ensures a highly interactive program. Since acquired and innate mechanisms of immunity can function independently or interactively to cause or exacerbate asthma, we have chosen to use allergens and/or irritants (endotoxin and ozone) in the proposed projects to narrow the exposure-response phenotype and investigate the pathogenesis and genetics of environmental airway disease. The end result is a highly integrated and focused program that has the potential to make a number of novel, related observations. The primary hypothesis unifying this research program is that investigating environmental airway disease by modeling biologically unique gene-environment-asthma phenotypes will advance our understanding of the pathogenesis and genetics of asthma. The project-specific hypotheses proposal are: Project 1: Polymorphisms of genes expressed by airway cells in asthmatics following specific subsegmental airway challenges predispose individuals to the development of asthma. Project 2: Integrating the assessment of the environmental risk factors with an enhanced understanding of specific asthma susceptibility genes will lead to a coherent understanding of the relationship between genes, environment, and the development of asthma in an African American population. Project 3: Specific gene polymorphisms/mutations contribute to differential susceptibility to Oa-induced lung injury in asthmatic and normal subjects, and specific acquired host factors regulate injury from exposure to O3. Project 4: Alteration in airway SNO metabolism is important in the pathogenesis of asthma resulting in the dysregulation of airway cell apoptosis that contributes to the acute and chronic inflammatory changes seen in asthma. In aggregate, the coupled scientific findings in this program will substantially enhance our understanding of the pathogenesis and genetics of asthma.
该计划项目拨款(P01)的总体主题是通过研究环境气道疾病进一步了解哮喘的发病机制和遗传学。我们为 PPG 选择这个主题的原因如下:1)哮喘的症状和体征构成了广泛的临床表型; 2)哮喘是一种复杂的遗传性疾病,由许多生物学上独特的基因-基因以及基因-环境相互作用引起; 3)气道疾病的环境模型 有助于缩小哮喘的生物学表型,为研究这种复杂疾病的发病机制和遗传学提供理想的机会; 4) 该主题建立在现有科学专业知识的基础上,并确保项目具有高度互动性。由于获得性和先天性免疫机制可以独立或相互作用地发挥作用,导致或加剧哮喘,因此我们选择在拟议的方案中使用过敏原和/或刺激物(内毒素和臭氧) 缩小暴露反应表型并研究环境气道疾病的发病机制和遗传学的项目。最终结果是一个高度集成且重点突出的计划,有可能做出许多新颖的相关观察。统一该研究计划的主要假设是,通过对生物学上独特的基因-环境-哮喘表型进行建模来研究环境气道疾病,将增进我们对哮喘发病机制和遗传学的理解。具体项目假设提案为: 项目 1:哮喘患者在特定亚段气道挑战后气道细胞表达的基因多态性使个体易患哮喘。 项目 2:将对环境风险因素的评估与对特定哮喘易感基因的深入了解相结合,将有助于对非裔美国人群体中基因、环境和哮喘发展之间的关系有一个连贯的了解。 项目 3:特定的基因多态性/突变导致哮喘和正常受试者对 Oa 引起的肺损伤的易感性存在差异,并且特定的获得性宿主因素调节暴露于 O3 造成的损伤。 项目 4:气道 SNO 代谢的改变在哮喘发病机制中很重要,导致气道细胞凋亡失调,从而导致急性和慢性炎症变化 哮喘。总的来说,该计划中的相关科学发现将大大增强我们对哮喘发病机制和遗传学的理解。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Proteomic analysis of human bronchoalveolar lavage fluid after subsgemental exposure.
  • DOI:
    10.1021/pr400066g
  • 发表时间:
    2013-05-03
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Foster MW;Thompson JW;Que LG;Yang IV;Schwartz DA;Moseley MA;Marshall HE
  • 通讯作者:
    Marshall HE
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David A Schwartz其他文献

Identification of pathologic features associated with ╜ulcerative colitis-like╚ Crohn╎s disease
鉴定与“溃疡性结肠炎样”克罗恩病相关的病理特征
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Samuel D James;Paul E Wise;Tania Zuluaga;David A Schwartz;M. Kay;Chanjuan Shi
  • 通讯作者:
    Chanjuan Shi
Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients
家族性肺纤维化患者亲属的临床前间质性肺疾病
  • DOI:
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sionne EM Lucas;Kelsie Raspin;J. Mackintosh;I. Glaspole;P. Reynolds;Collin Chia;Christopher Grainge;Peter Kendall;Lauren Troy;David A Schwartz;R. Wood;S. Walsh;Y. Moodley;James Robertson;Sacha;Macansh;E. Walters;Daniel C. Chambers;T. Corte;L. Joanne;Dickinson
  • 通讯作者:
    Dickinson
Thrombolytic therapy of massive pulmonary embolism during prolonged cardiac arrest using recombinant tissue-type plasminogen activator
  • DOI:
    10.1016/s0196-0644(89)80527-x
  • 发表时间:
    1989-06-01
  • 期刊:
  • 影响因子:
  • 作者:
    Robert W Langdon;William R Swicegood;David A Schwartz
  • 通讯作者:
    David A Schwartz

David A Schwartz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David A Schwartz', 18)}}的其他基金

THE GENETICS OF ENVIRONMENTAL ASTHMA
环境性哮喘的遗传学
  • 批准号:
    7198457
  • 财政年份:
    2005
  • 资助金额:
    $ 146.02万
  • 项目类别:
ROLE OF RHUMAB-E25 IN DECREASING EXHALED NO IN PATIENTS WITH ALLERGIC ASTHMA
RHUMB-E25 在减少过敏性哮喘患者呼出气体中的作用
  • 批准号:
    7198471
  • 财政年份:
    2005
  • 资助金额:
    $ 146.02万
  • 项目类别:
The Genetics of Environmental Asthma
环境性哮喘的遗传学
  • 批准号:
    6974021
  • 财政年份:
    2004
  • 资助金额:
    $ 146.02万
  • 项目类别:
RhuMAB-E25 in Decreasing Exhaled NO in Patients w/Asthma
RhuMAB-E25 减少哮喘患者呼出一氧化氮
  • 批准号:
    6974039
  • 财政年份:
    2004
  • 资助金额:
    $ 146.02万
  • 项目类别:
A Linkage Study in Familial Pulmonary Fibrosis
家族性肺纤维化的关联研究
  • 批准号:
    6974015
  • 财政年份:
    2004
  • 资助金额:
    $ 146.02万
  • 项目类别:
Center for Comparative Biology of Vulnerable Populations
弱势群体比较生物学中心
  • 批准号:
    6704015
  • 财政年份:
    2004
  • 资助金额:
    $ 146.02万
  • 项目类别:
CENTER FOR ENVIRONMENATL GENOMICS
环境基因组学中心
  • 批准号:
    6655584
  • 财政年份:
    2001
  • 资助金额:
    $ 146.02万
  • 项目类别:
CENTER FOR ENVIRONMENTAL GENOMICS
环境基因组学中心
  • 批准号:
    6438972
  • 财政年份:
    2001
  • 资助金额:
    $ 146.02万
  • 项目类别:
MODEL TO STUDY THE ORIGIN OF PERSISTENT ENVIRONMENTAL AIRWAY DISEASE
研究持续性环境气道疾病起源的模型
  • 批准号:
    6564454
  • 财政年份:
    2001
  • 资助金额:
    $ 146.02万
  • 项目类别:
CENTER FOR INVIRONMENATL GENOMICS
环境基因组学中心
  • 批准号:
    6524823
  • 财政年份:
    2001
  • 资助金额:
    $ 146.02万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 146.02万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 146.02万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 146.02万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 146.02万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 146.02万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 146.02万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 146.02万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 146.02万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 146.02万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 146.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了